These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19499455)

  • 1. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.
    Kumar AM; Fernandez JB; Singer EJ; Commins D; Waldrop-Valverde D; Ownby RL; Kumar M
    J Neurovirol; 2009 May; 15(3):257-74. PubMed ID: 19499455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
    Kumar AM; Ownby RL; Waldrop-Valverde D; Fernandez B; Kumar M
    J Neurovirol; 2011 Feb; 17(1):26-40. PubMed ID: 21165787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction.
    Kumar AM; Borodowsky I; Fernandez B; Gonzalez L; Kumar M
    J Neurovirol; 2007 Jun; 13(3):210-24. PubMed ID: 17613711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Para-o-methylation of dopamine in human brain.
    Ebinger G; Verheyden R
    Acta Neurol Belg; 1975; 75(2):111. PubMed ID: 1155020
    [No Abstract]   [Full Text] [Related]  

  • 5. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
    Walsh FX; Stevens TJ; Langlais PJ; Bird ED
    Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.
    Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y
    Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--II. Studies using ibotenic acid injection of the parafascicular-intralaminar nuclei.
    Kilpatrick IC; Jones MW; Johnson BJ; Cornwall J; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):979-90. PubMed ID: 3796824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
    Quik M; Polonskaya Y; Gillespie A; K Lloyd G; Langston JW
    Neuroscience; 2000; 100(1):63-72. PubMed ID: 10996459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey.
    Bird ED; Anton AH; Bullock B
    Neurotoxicology; 1984; 5(1):59-65. PubMed ID: 6538950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Kosaka K; Iizuka R
    J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE; Landis DM; Zalneraitis EL
    Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.
    Langford D; Marquie-Beck J; de Almeida S; Lazzaretto D; Letendre S; Grant I; McCutchan JA; Masliah E; Ellis RJ
    J Neurovirol; 2006 Apr; 12(2):100-7. PubMed ID: 16798671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
    Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
    Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
    Jaffer A; van der Spuy GD; Russell VA; Mintz M; Taljaard JJ
    Neurodegeneration; 1995 Jun; 4(2):139-45. PubMed ID: 7583677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine in thelimbic regions of the human brain: normal and abnormal.
    Farley IJ; Price KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1977; 16():57-64. PubMed ID: 883559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.
    Silvers JM; Aksenov MY; Aksenova MV; Beckley J; Olton P; Mactutus CF; Booze RM
    J Neurovirol; 2006 Apr; 12(2):140-5. PubMed ID: 16798675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.